OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.21BP/E –Yield –
OPKO Health total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
OPKO Health's total debt was $2.69M at Jun 30, 2026. For fiscal 2025 it was $4.00M, down 99.1% from the year before. Over ten years it grew -12.9% a year on average. The highest annual figure on record is $440.21M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.00M | -99.1% |
| FY2024 | Dec 31, 2024 | $440.21M | +4428.9% |
| FY2023 | Dec 31, 2023 | $9.72M | -11.7% |
| FY2022 | Dec 31, 2022 | $11.01M | +186.9% |
| FY2020 | Dec 31, 2020 | $3.84M | -1.8% |
| FY2019 | Dec 31, 2019 | $3.91M | -62.8% |
| FY2018 | Dec 31, 2018 | $10.51M | -22.1% |
| FY2017 | Dec 31, 2017 | $13.49M | +6.3% |
| FY2016 | Dec 31, 2016 | $12.70M | -9.2% |
| FY2015 | Dec 31, 2015 | $13.99M | -11.9% |
| FY2014 | Dec 31, 2014 | $15.89M | +0.4% |
| FY2013 | Dec 31, 2013 | $15.83M | -30.2% |
| FY2012 | Dec 31, 2012 | $22.68M | +158.9% |
| FY2011 | Dec 31, 2011 | $8.76M | -40.4% |
| FY2010 | Dec 31, 2010 | $14.69M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.69M | -37.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.54M | -17.0% |
| Q4 FY2025 | Dec 31, 2025 | $4.00M | -99.1% |
| Q3 FY2025 | Sep 30, 2025 | $3.97M | -21.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.29M | -18.6% |
| Q1 FY2025 | Mar 31, 2025 | $4.26M | -27.3% |
| Q4 FY2024 | Dec 31, 2024 | $440.21M | +4428.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.04M | -48.1% |
| Q2 FY2024 | Jun 30, 2024 | $5.27M | -52.7% |
| Q1 FY2024 | Mar 31, 2024 | $5.86M | -46.8% |
| Q4 FY2023 | Dec 31, 2023 | $9.72M | +481.7% |
| Q3 FY2023 | Sep 30, 2023 | $9.70M | +144.3% |
| Q2 FY2023 | Jun 30, 2023 | $11.16M | +235.6% |
| Q4 FY2022 | Dec 31, 2022 | $11.01M | +186.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.67M | -58.3% |
| Q2 FY2021 | Jun 30, 2021 | $3.97M | -5.5% |
| Q1 FY2021 | Mar 31, 2021 | $3.33M | -6.0% |
| Q4 FY2020 | Dec 31, 2020 | $3.84M | -1.8% |
| Q3 FY2020 | Sep 30, 2020 | $4.01M | -2.0% |
| Q2 FY2020 | Jun 30, 2020 | $4.20M | -6.6% |
| Q1 FY2020 | Mar 31, 2020 | $3.54M | -18.1% |
| Q4 FY2019 | Dec 31, 2019 | $3.91M | -62.8% |
| Q3 FY2019 | Sep 30, 2019 | $4.09M | +258.2% |
| Q2 FY2019 | Jun 30, 2019 | $4.50M | +164.1% |
| Q1 FY2019 | Mar 31, 2019 | $4.32M | +201.8% |
| Q4 FY2018 | Dec 31, 2018 | $10.51M | -22.1% |
| Q3 FY2018 | Sep 30, 2018 | $1.14M | -93.4% |
| Q2 FY2018 | Jun 30, 2018 | $1.70M | -89.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.43M | -89.0% |
| Q4 FY2017 | Dec 31, 2017 | $13.49M | +6.3% |
| Q3 FY2017 | Sep 30, 2017 | $17.27M | +42.4% |
| Q2 FY2017 | Jun 30, 2017 | $16.06M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.99M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.70M | – |
| Q3 FY2016 | Sep 30, 2016 | $12.13M | – |
See a number that looks wrong?